General MedicationsINJECTIONStandard

ERYTHROMYCIN LACTOBIONATE

Standard Dose

EQ 500MG BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ERYTHROMYCIN LACTOBIONATE is listed in Drugs@FDA under application 216761 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ERYTHROMYCIN LACTOBIONATE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor GLAND Submission history Latest submission status date: 2024-11-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN LACTOBIONATE is listed in Drugs@FDA under application 216761 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ERYTHROMYCIN LACTOBIONATE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor GLAND Submission history Latest submission status date: 2024-11-19 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.